Antiparasitic Drugs Market Size, Share, Outlook, and Opportunity Analysis, 2020– 2027

1. ANTIPARASITIC DRUGS MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

2. REPORT DESCRIPTION Antiparasitic Drugs Market - Overview The Global Antiparasitic Drugs Market, by Drug Class (Anthelmintics (Benzimidazoles, Pyrantel, Niclosamide, Praziquantel, and Others), Antiprotozoals (Antimalarial Drugs-Aminoquinolines, Quinoline-methanol (4-quinolinemethanols), Cinchona Alkaloids, Biguanides, Sulfonamides and sulfones, Others), and Other Antiprotozoal Agents), and Others (Pediculocides & miticulocides) (Lindane, Malathion, Pyrethrins, and Others), by Route of Administration (Oral, Injectable, and Topical), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), was valued at US$ 7,227.9 million in 2019 and is expected to exhibit a CAGR of 5.2% during the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights. The increasing launches of antiparasitic drugs is expected to propel growth of the global antiparasitic drugs market during the forecast period. For instance, in August 2019, Teva Pharmaceuticals launched an AB-rated generic version of Galderma’s Soolantra (ivermectin) cream indicated for the treatment of inflammatory lesions of rosacea. Moreover, in January 2018, Perrigo Company plc. received tentative U.S. Food and Drug Administration approval to launch generic version of the Soolantra (ivermectin) cream. Browse 42 Market Data Tables and 40 Figures spread through 182 Pages and in-depth TOC on 'Global Antiparasitic Drugs Market. Browse Research Reports: https://www.coherentmarketinsights.com/market- insight/antiparasitic-drugs-market-3782 © Coherent market Insights. All Rights Reserved

3. REPORT DESCRIPTION Initiatives taken by government and non-profit organizations to create awareness related to the parasitic diseases among the population and providing proper treatment is contributing to the market growth. Moreover, these organization are focusing on establishing new research and development centers in high risk tropical and subtropical regions. For instance, in June 2018, the University of California San Diego launched a new Center for Anti-Parasitic Drug Discovery and Development at San Diego which includes 15 research and clinical facilities. Furthermore, the increasing prevalence of parasitic infections such as Chagas Disease is expected to drive the market growth. According to the World Health Organization (WHO) estimation, in March 2020, around 6-7 million people across the globe are expected to be diagnosed with Chagas Disease, a parasitic infection caused due the Trypansosoma cruzi parasite. The WHO also stated that majority of the affected population is from the Latin America region. The Chagas Disease can be well treated with benznidazole and nifurtimox. Thus, the increasing prevalence of the Chagas disease is expected to drive demand for these drugs in the region. Anthelmintics (Benzimidazoles, Pyrantel, Niclosamide, Praziquantel, and Others), Antiprotozoals (Antimalarial Drugs-Aminoquinolines, Quinoline-methanol (4- quinolinemethanols), Cinchona Alkaloids, Biguanides, Sulfonamides and sulfones, Others), and Other Antiprotozoal Agents), and Others (Pediculocides & miticulocides) (Lindane, Malathion, Pyrethrins, and Others), Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/3782 © Coherent market Insights. All Rights Reserved

4. REPORT DESCRIPTION Key Takeaways of the Global Antiparasitic Drugs Market: The global antiparasitic drugs market is expected to exhibit a CAGR of 5.2% during the forecast period (2020–2027) owing to initiatives taken by various research organizations to develop novel drugs for treating parasitic diseases. For instance, on April 23, 2019 Lupin Research Inc. initiated phase 3 study to evaluate the effectiveness, and safety of a single, oral dose of Solosec containing 2 grams of secnidazole in female patients with trichomoniasis. The study is estimated to be completed in 2020. Among drug class, antiprotozoals is expected to hold significant market share in antiparasitic drugs market owing to the growing demand for antimalarial drugs in key regions such as India and other South-east Asian countries, as well as high prevalence of malaria in these countries is expected to drive growth of antiparasitic drugs market. For instance, according to the WHO, in 2017, around 3 million cases of malaria were diagnosed in India. Moreover, the WHO stated that in 2019, India accounted for 21% of the total deaths in South-east Asia region. Major players operating in the global antiparasitic drugs market are Ipca Laboratories Ltd., Zydus Cadila, Merck KGaA, Pfizer, GlaxoSmithKline Plc., Cipla Ltd, Ranbaxy Laboratories, Novartis AG, Alvizia Health Care, Bayer AG, Roche Inc., Arbor Pharmaceuticals Inc., Sanofi, AstraZeneca plc. and Alkem Laboratories Limited. Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/3782 © Coherent market Insights. All Rights Reserved

5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved